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Background
The genus Yersinia belongs to the family Enterobacteriaceae 
and contains gram-negative, pleomorphic, facultative 
anaerobic and oxidase-negative rods with bipolar 
staining.1,2 Among 15 identified Yersinia species, three 
are pathogenic to humans including Yersinia pestis 
and two food-borne pathogens that are the cause of 
enteric diseases, i.e., Yersinia enterocolitica and Yersinia 
pseudotuberculosis.1,2 Human is an accidental host for 
these zoonotic bacterial pathogens. 2 Y. pestis causes 
plague which is a rare infection in human, and rats are the 
natural reservoirs for human infection.2 Streptomycin, 
tetracyclines, chloramphenicol, trimethoprim/
sulfamethoxazole and gentamicin are the preferred 
choices for treating this zoonotic infection. Moreover, 
sulfonamide, trimethoprim/sulfamethoxazole and 
tetracycline are recommended for plague prophylaxis.2,3 
However, the emergence of high-level resistance to 
antimicrobial agents was observed in a clinical isolate 
of Y. pestis in 1995.3 Y. pseudotuberculosis is a relatively 
uncommon causative agent of yersiniosis in human, 
which can be transferred from the natural reservoirs such 
as wild and domestic animals and birds.4 Acute or chronic 
Y. pseudotuberculosis infections in human are transmitted 
through contaminated food or water, and the severity of 
infections vary from self-limiting infection to sepsis with 
a mortality rate as high as >75%.4,5 Y. enterocolitica is the 
most common human pathogen of Yersinia species and 
is ubiquitously present in water, milk, soil, and domestic 
and wild animals including pigs, rodents, livestock, and 
rabbits.6,7 Yersiniosis is a gastrointestinal infection caused 
by this psychrotrophic bacterium (Y. enterocolitica) 
and is most common among infants and young 
children under the age of five, especially in developing 
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Abstract
Objective: The aim of the present study was to investigate the antimicrobial susceptibility profiles 
of Yersinia species, especially Y. enterocolitica from non-clinical and clinical isolates in Iran. 
Materials and Methods: We systematically searched PubMed, Scopus, Google Scholar, and the 
Scientific Information Database (SID) using “antibiotic resistance”, “Yersinia”, and “Iran” as major 
keywords until June 10, 2019. According to the predefined article selection criteria, published 
studies addressing the epidemiology of antibiotic-resistant Yersinia species in Iran were included 
in the meta-analysis. Data were extracted and exported to the Comprehensive Meta-Analysis 
Software to evaluate antibiotic resistance rates, heterogeneity of studies and publication bias. 
Results: Twelve studies reported antimicrobial susceptibility testing using disk diffusion method. 
The pooled prevalence of antibiotic-resistant Yersinia species in food and clinical specimens in Iran 
was as follows: 22.4% to amoxicillin, 41.9% to ampicillin, 6% to gentamicin, 17% to trimethoprim/
sulfamethoxazole, 19% to tetracycline, 10.3% to ciprofloxacin, 10.5% to streptomycin, 3.8% to 
chloramphenicol, 79.3% to cephalothin, 18.4% to nalidixic acid, 6.6% to cefotaxime, and 12.2% 
to trimethoprim.
Conclusion: This study revealed a high prevalence of resistant Y. enterocolitica strains isolated from 
food and clinical specimens in Iran to β-lactams, while the resistance rates to aminoglycosides, 
fluoroquinolone and chloramphenicol were low. Our findings recommended the necessity 
of a continuous surveillance of the resistance patterns and prudent use of trimethoprim/
sulfamethoxazole, tetracycline, and nalidixic acid to prevent the development of antibiotic-
resistant Y. enterocolitica strains in Iran.
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countries.8 This food-borne disease is transmitted via 
the fecal-oral route after digestion of contaminated food 
products and water and is considered as a public health 
challenge especially in terms of food safety due to its 
ability to grow at 4°C.9 In immunocompetent hosts, the 
bacterium causes local infection in the gastrointestinal 
tract, which is characterized as a mild and self-limiting 
diarrhea. However, antimicrobial therapy is required in 
immunocompromised patients due to the risk of systemic 
infection with a high mortality rate (50%).4,6,7,9 Because 
of the high bacterial susceptibility to broad-spectrum 
cephalosporins, aminoglycosides, chloramphenicol, 
tetracyclines, trimethoprim/sulfamethoxazole and 
ciprofloxacin, these drugs are recommended by the 
World Health Organization (WHO) for treatment of 
human invasive infections caused by Y. enterocolitica.2,9 
However, some of these antibiotics have also been used 
for growth promotion, prophylaxis, and treatment in 
food-producing animals, which has led to the emergence 
of antimicrobial-resistant strains followed by transferring 
these antimicrobial-resistant food-borne pathogens to 
humans.10 Hitherto, there has been no comprehensive 
information about the epidemiology of antibiotic-
resistant Yersinia species in Iran. Therefore, the aim of this 
systematic review and meta-analysis was to investigate the 
antimicrobial susceptibility profiles of Yersinia species, 
especially Y. enterocolitica among non-clinical and clinical 
isolates in Iran.
Materials and Methods
Data Sources and Search Strategies
The study protocol was in accordance with PRISMA (the 
Preferred Reporting Items for Systematic Review and 
Meta-Analysis) checklist.11 The main sources of data to 
investigate the prevalence of antimicrobial susceptibility 
profiles of Yersinia species in Iran in international and 
national databases were PubMed (https://www.ncbi.
nlm.nih.gov), Scopus (https://www.scopus.com), Google 
Scholar (http://scholar.google.com), and the Scientific 
Information Database (SID) (www.sid.ir). Using some 
major keywords, i.e., “antibiotic resistance”, “Yersinia”, 
“Iran” and with the help of boolean operators (AND and 
OR) and the truncation mark (*), a complete search was 
performed in databases until June 10, 2019 followed by 
a supplementary literature search in the reference lists of 
included articles to identify eligible studies for the meta-
analysis.
Screening of Studies and Selection Criteria
Collected records during literature search process were 
further evaluated for eligibility based on the inclusion and 
exclusion criteria. To start, duplicate records were removed 
through screening of titles. Then, the abstracts and full 
texts were screened by two investigators independently 
according to the inclusion criteria. Persian- and English-
language articles containing sufficient and extractable 
data and studies focusing on antibiotic resistance rate of 
Yersinia species only in Iran were included in the study. 
Records other than cross-sectional studies, food and 
clinical specimens and Yersinia species, incomplete data 
and duplicate publications were excluded from the meta-
analysis.
Data Extraction and Quality Assessment of Studies
A full-text review of articles meeting eligibility criteria 
was done in order to extract data and perform quality 
assessment of studies. Data were extracted for each study 
and sorted by first author details, area of the study, year 
of the study, type and number of Yersinia species isolated 
from different specimens, origin of samples, antibiotic 
susceptibility test methods and number of resistant 
Yersinia isolates for each species. Then, the quality of 
included studies was assessed using the Joanna Briggs 
Institute (JBI) checklist presented by Munn et al for 
studies reporting prevalence data.12 The JBI checklist 
contained some items about the target population, 
sample size, statistical analysis, and methods used for the 
identification, and eligible studies receiving more than 
5 scores were considered as high-quality, 4–5 scores as 
medium-quality and lower than 4 scores as low-quality 
studies (Table 1).
Data Processing and Analysis
All statistical analyses were performed using the CMA 
(Comprehensive Meta-Analysis) software, version 2.2 
(Biostat, Englewood, NJ). The resistance rates of Yersinia 
species among included studies were determined using 
forest plots of pooled event rates and expressed as 
percentage and 95% confidence intervals (CIs). Subgroup 
analysis was done based on type of Yersinia species. Data 
analysis and synthesis were done by combining at least 
four studies. Depending on the existence of heterogeneity 
among included studies, data on the antibiotic resistance 
were pooled using random- or fixed-effects models. 
Heterogeneity degree of the studies was determined with 
the help of the I2 statistic (25% (low), 50% (moderate), 
and 75% (high)) and the Chi-square test with Cochran’s Q 
statistic (significant at P < 0.1). A potential publication bias 
in articles reporting resistance rate for each antibiotic was 
investigated through visually observation of symmetry in 
funnel plots.
Results
As shown in Figure 1, a total of 12 studies were selected 
for meta-analysis among 1019 identified citations 
through database searching. Y. enterocolitica (61.3%), 
Y. frederiksenii (12.2%) and Y. intermedia (6.1%) were 
the most common species of the genus Yersinia and 
their antibiotic resistance rates was investigated in the 
included articles through disk diffusion method in 
Iran. Additionally, Y. enterocolitica strains were isolated 
from both non-clinical and clinical samples, while Y. 
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frederiksenii and Y. intermedia strains were isolated 
only from non-clinical samples. In this study, 91.6% of 
Yersinia species were isolated from the food products 
including milk, chicken and beef meats as well as duck 
and goose intestinal contents and 8.4% from the clinical 
samples. Clinical samples were diarrheal stool, blood, 
cerebrospinal fluid (CSF), urine and wound. As shown 
in Table 1, eligible studies were from Ahvaz, Behshahr, 
Fuladshahr, Hamadan, Qom and Tehran with quality 
scores of ≥5. We assessed the resistance prevalence of 
Yersinia species and the potential publication bias for each 
antibiotic using forest plots (Figures 2A, B and C) and 
funnel plots (Figures 3A, B and C), respectively. Overall 
resistance prevalence of Yersinia species against selected 
antimicrobial agents that were isolated from food products 
and clinical specimens in Iran was as follows: 22.4% (95% 
CI: 4.8-62.3; I2 = 88.7%; Q = 53.1; P = 0.00) to amoxicillin, 
41.9% (95% CI: 29-56.1; I2 = 71.9%; Q = 49.8; P = 0.00) to 
ampicillin, 6% (95% CI: 2.8-12.4; I2 = 30.8%; Q = 23.1; P 
= 0.11) to gentamicin, 17% (95% CI: 10.5-26.3; I2 = 0.0%; 
Q = 7.8; P = 0.44) to trimethoprim/sulfamethoxazole, 
19% (95% CI: 11.8-29.2; I2 = 58.8%; Q = 33.9; P = 0.00) 
to tetracycline, 10.3% (95% CI: 3.6-26.2; I2 = 80.8%; Q = 
78.2; P = 0.00) to ciprofloxacin, 10.5% (95% CI: 7-15.3; I2 
= 0.0%; Q = 8.3; P = 0.76) to streptomycin, 3.8% (95% CI: 
1.9-7.6; I2 = 0.0%; Q = 5; P = 0.98) to chloramphenicol, 
79.3% (95% CI: 60.6-90.5; I2 = 80.4%; Q = 76.7; P = 0.00) 
to cephalothin, 18.4% (95% CI: 13.9-23.9; I2 = 11.1%; Q 
= 14.6; P = 0.33) to nalidixic acid, 6.6% (95% CI: 1.9-
20.8; I2 = 39.9%; Q = 11.6; P = 0.11) to cefotaxime and 
12.2% (95% CI: 8.1-17.9; I2 = 0.0%; Q = 6; P = 0.64) to 
trimethoprim. Finally, we performed a subgroup analysis 
of antibiotic resistance profile of Yersinia species against 
selected antibiotics (Table 2).
Discussion
Our study on the prevalence of antibiotic-resistant Yersinia 
species in both food products and clinical samples in Iran 
showed high resistance rates against amoxicillin (22.4%), 
ampicillin (41.9%), trimethoprim/sulfamethoxazole 
(17%), tetracycline (19%), cephalothin (79.3%), nalidixic 
acid (18.4%), and trimethoprim (12.2%). In contrast, low 
resistance rates against gentamicin (6%), ciprofloxacin 
(10.3%), streptomycin (10.5%), chloramphenicol (3.8%), 
and cefotaxime (6.6%) were found. Among Yersinia 
species, Y. enterocolitica was the most common species in 
the present study. Pigs are considered as the most important 
source of human Y. enterocolitica infection in the world.9 
However, for religious reasons, pigs are not used in Iran 
and as shown in Table 1, milk, chicken and beef were the 
main sources of Y. enterocolitica in Iran.20 Given that these 
kinds of food products are important sources of nutrients 
for Iranian people, there is a high risk of the outbreak 
of Y. enterocolitica-induced enteric infections associated 
with the consumption of contaminated food products in 
Iran. On the other hand, in this study, the prevalence of Y. 
enterocolitica strains isolated from the clinical samples was 
low. Studies have reported that clinical Y. enterocolitica 
infections were relatively infrequent in Iran, which can be 
explained by fact that Yersinia species are not routinely 
screened in most clinical laboratories.14,20 Therefore, 
improving identification procedures for Y. enterocolitica 
from different samples is necessary to determine the 
Figure 1. PRISMA Flow Diagram Describing the Study Selection 
Process
Figure 2. Forest Plots Showing the Prevalence of Antibiotic Resistance of 
Y. enterocolitica to Cephalothin (A), Gentamicin (B) and Tetracycline (C) in 
Food and Clinical Specimens.
(A)
(B)
(C)
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Figure 3. Funnel Plots Showing Publication Bias of Studies Addressing the Prevalence of Antibiotic Resistance of Y. enterocolitica to Cephalothin (A), Gentamicin 
(B) and Tetracycline (C) in Food and Clinical Specimens.
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epidemiology of this microorganism. However, a more 
important issue is excessive administration of some 
antibiotics, i.e., tetracycline and ciprofloxacin for growth 
promotion, disease prevention and treatment of diseases 
in animals in Iran. This excessive use results in the 
emergence of antibiotic-resistant strains.20,23 Our findings 
indicated that the prevalence of Y. enterocolitica strains 
resistant to tetracycline and ciprofloxacin antibiotics in 
both food products and clinical samples was 18.3% and 
6%, respectively. Therefore, limiting the use of these 
antibiotics, especially tetracycline, in food-producing 
animals is recommended in order to prevent the emergence 
of antibiotic-resistant food-borne pathogens and their 
transmission to humans through food products. Reported 
resistance prevalence of Y. enterocolitica strains isolated 
from food products against quinolones, ciprofloxacin and 
nalidixic acid, and tetracycline in different countries is as 
follows: Italy (0%), China (1.4% to ciprofloxacin, 18.6% 
to nalidixic acid, and 8.6% to tetracycline), Austria (0%), 
Germany (0%), Turkey (0% to ciprofloxacin, 4.8% to 
nalidixic acid, and 4.8% to tetracycline), Korea (0%), and 
Malaysia (62.5% to nalidixic acid and tetracycline).25-31 
Reports have proven the resistance of Y. enterocolitica 
to first-generation cephalosporins and ampicillin.1 
Similarly, the resistance of Y. enterocolitica to β-lactams 
including amoxicillin (45.9%), ampicillin (50.3%), 
and cephalothin (83.3%) was high in Iran. This high 
percentage of resistance can be attributed to β-lactamases 
A and B produced by Y. enterocolitica.25 Similar results in 
accordance with our meta-analysis were observed for Y. 
enterocolitica strains isolated from food products in Italy 
(100% to ampicillin and cephalothin), China (98.6% to 
ampicillin and 95.7% to cephalothin), Germany (83.3% to 
amoxicillin, 50% to ampicillin, and 83.3% to cephalothin), 
Turkey (57.1% to amoxicillin, 64.3% to ampicillin, 
and 86.9% to cephalothin), Korea (94% to ampicillin 
and 100% to cephalothin) and Malaysia (92.6% to 
amoxicillin and 96.3% to ampicillin).25,26,28-31 Gentamicin 
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in combination with either fluoroquinolones or third-
generation cephalosporins was recommended in life-
threatening Y. enterocolitica infections, such as sepsis and 
meningitis.1, 9 Regarding aminoglycosides, gentamicin, 
and streptomycin, low levels of resistance have been 
reported among Y. enterocolitica strains isolated in Iran, 
which is in accordance with reports from Italy (0%), China 
(4.3% to gentamicin and 8.6% to streptomycin), Austria 
(0%), Germany (0%), Turkey (0% to gentamicin and 4.8% 
to streptomycin), and Korea (0%).25-30 The prevalence of 
resistance to other antibiotics used for the treatment of 
human yersiniosis (i.e., trimethoprim/sulfamethoxazole) 
was higher (17.1%) than those reported from Italy (0%)25 
and Malaysia,31 but lower than that of China (74.3%).26
Conclusion
Among Yersinia species, Y. enterocolitica was found as 
the most prevalent food-borne pathogen isolated from 
food products and clinical specimens in this research. 
Results revealed a high rate of contamination of food 
products and human specimens with β-lactams-resistant 
strains of Y. enterocolitica in Iran. Therefore, there is a 
risk of transmission of these antibiotic-resistant strains 
to humans through the consumption of food products. 
Furthermore, Y. enterocolitica strains in Iran were mostly 
susceptible to aminoglycosides, fluoroquinolone, and 
chloramphenicol, making these antibiotics relevant 
for human invasive infections. However, the present 
results suggested that resistance to trimethoprim/
sulfamethoxazole, tetracycline, and nalidixic acid was 
increasing in Iran, with a caveat of becoming a public 
health concern in the future. Therefore, to prevent the 
spread of bacterial antibiotic resistance and subsequent 
treatment failure, cautionary measures should be applied. 
These measures include (1) limiting the use of antibiotics 
in both animal and human (2) continuous monitoring 
of resistance, and (3) taking sanitary precautions such 
as consumption of pasteurized milk and cooked food 
products.
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